Source:http://linkedlifedata.com/resource/pubmed/id/18767923
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-17
|
pubmed:abstractText |
Age-related osteoporosis is characterized by low bone mass, poor bone quality, and impaired osteoblastogenesis. Recently, the Hutchinson-Gilford progeria syndrome (HGPS), a disease of accelerated aging and premature osteoporosis, has been linked to mutations in the gene encoding for the nuclear lamina protein lamin A/C. Here, we tested the hypothesis that inhibition of lamin A/C in osteoblastic lineage cells impairs osteoblastogenesis and accelerates osteoclastogenesis. Lamin A/C was knocked-down with small interfering (si)RNA molecules in human bone marrow stromal cells (BMSCs) differentiating toward osteoblasts. Lamin A/C knockdown led to an inhibition of osteoblast proliferation by 26% and impaired osteoblast differentiation by 48% based on the formation of mineralized matrix. In mature osteoblasts, expression levels of runx2 and osteocalcin mRNA were decreased by lamin A/C knockdown by 44% and 78%, respectively. Furthermore, protein analysis showed that osteoblasts with diminished levels of lamin A/C also secreted less osteocalcin and expressed a lower alkaline phosphatase activity (-50%). Lamin A/C inhibition increased RANKL mRNA and protein levels, whereas osteoprotegerin (OPG) expression was decreased, resulting in an increased RANKL/OPG ratio and an enhanced ability to support osteoclastogenesis, as reflected by a 34% increase of TRACP(+) multinucleated cells. Our data indicate that lamin A/C is essential for proper osteoblastogenesis. Moreover, lack of lamin A/C favors an osteoclastogenic milieu and contributes to enhanced osteoclastogenesis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1523-4681
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
78-86
|
pubmed:dateRevised |
2011-4-6
|
pubmed:meshHeading |
pubmed-meshheading:18767923-Alkaline Phosphatase,
pubmed-meshheading:18767923-Bone Marrow Cells,
pubmed-meshheading:18767923-Bone Resorption,
pubmed-meshheading:18767923-Cell Differentiation,
pubmed-meshheading:18767923-Cell Lineage,
pubmed-meshheading:18767923-Cell Proliferation,
pubmed-meshheading:18767923-Cells, Cultured,
pubmed-meshheading:18767923-Humans,
pubmed-meshheading:18767923-Lamin Type A,
pubmed-meshheading:18767923-Microscopy, Electron, Scanning,
pubmed-meshheading:18767923-Osteoblasts,
pubmed-meshheading:18767923-Osteoclasts,
pubmed-meshheading:18767923-Progeria,
pubmed-meshheading:18767923-RANK Ligand
|
pubmed:year |
2009
|
pubmed:articleTitle |
Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis.
|
pubmed:affiliation |
Institute of Pathophysiology, Medical University of Vienna, Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|